The market is expected to face a bear attack given the prevailing bearish momentum and rising US-Iran tensions. Below are some short-term trading ideas to consider.
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.
Consolidation is likely to continue as long as the index trades below the downward-sloping resistance trendline. Below are some short-term trading ideas to consider.
The market is expected to consolidate with range-bound trading. Below are some short-term trading ideas to consider.
The market may remain range-bound until it decisively breaks the current week’s high–low range. Below are some short-term trading ideas to consider.
The Nifty IT index is trading comfortably above its 200-day EMA, reinforcing the ongoing strength in its structure, said Sudeep Shah.
Deven Choksey recommended reduce rating on Laurus Labs with a target price of Rs 900 in its research report dated October 28, 2025.
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1110 in its research report dated October 23, 2025.
Choice Equity Broking is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated October 24, 2025.
The CDMO business for small molecules grew 58 percent YoY in Q2FY26, helped by a ramp-up in sales from new manufacturing assets
The market needs to surpass short- and medium-term moving averages for a persistent uptrend. Below are some short-term trading ideas to consider.
On July 25, Laurus Labs reported a whopping 1,154% jump in its net profit in June quarter at Rs 163 crore
Overall, the trend continues to favour the bulls, although some consolidation may occur following a two-week rally. Below are some short-term trading ideas to consider.
Drug discovery and development collaboration are the key drivers for the Indian CDMO industry.
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 750 in its research report dated April 24, 2025.
Choice Equity Broking is bullish on Laurus Lab recommended buy rating on the stock with a target price of Rs 750 in its research report dated April 25, 2025.
The benchmark indices are likely to be rangebound in the upcoming sessions. Below are some trading ideas for the near term.